Cytonome Inc

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.

Translate Bio is a biotechnology company based in Lexington, MA that focuses on developing mRNA therapeutics for various diseases. The company's research and development efforts are centered around leveraging mRNA technology to create potential treatments for a range of medical conditions. Translate Bio's work in the field of mRNA therapeutics aims to address unmet medical needs and advance the understanding of this innovative approach to healthcare. Through its research initiatives, the company seeks to contribute to the advancement of personalized medicine and improve patient outcomes. Generated from their business information

Aphios Corporation is a biopharmaceutical company that develops enhanced natural therapeutics for infectious diseases, cancer and quality-of-life medicines. The company s business strategy is to collaborate with multinational companies, such as Novartis, Bayer, Bristol-Myers Squibb, Eli Lilly and the Gillette Company, to develop enhanced therapeutic products. The resulting technology platforms and therapeutic products have garnered approximately 30 United States and international patents with several applications pending. Its product pipeline includes SuperCool Gingerol, a pill for aiding digestion; Zindol, a pill that mitigates nausea caused by chemotherapy and motion and morning sickness; Xantol, a pill to treat mild to moderate depression and anxiety; and LoTax, an intravenous medication for breast and ovarian cancer. Aphios is also developing antiviral therapeutics against HIV, influenza, smallpox and SARS. The company maintains its headquarters in Woburn, Mass.